Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06110403 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and Breathlessness

Study acronym: VARI-OSCIL
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 18, 2025 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Sep 2025 to Sep 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University Hospital, Lille
343 trials monitored
See 5 trials at risk
COPD
1,119 trials monitored
See 34 trials at risk
Multicentre, prospective, non-randomised, single-arm, open label, mechanistic study to investigate the mechanism of action of BGF 160 on ventilation pattern complexity and variability
Trial Details
NCT Number NCT06110403
Lead Sponsor University Hospital, Lille
Collaborators: AstraZeneca
Conditions
(from sponsor)		 Copd
Related terms Dyspnea, Pulmonary Disease, Chronic Obstructive
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov